36131783|t|Outcome of Lenalidomide Treatment for Cognitive Impairment Caused by Immune Reconstitution Inflammatory Syndrome in Patients with HIV-Related Cryptococcal Meningitis.
36131783|a|Purpose: Cognitive impairment associated with human immunodeficiency virus (HIV)-related cryptococcal meningitis (HCM) in the context of immune reconstitution inflammatory syndrome is difficult to address. This study was a follow-up of lenalidomide treatment outcomes in patients with HCM and cognitive impairment after complete cryptococcal clearance. Patients and Methods: Seven HCM patients with neuroinflammation and cognitive impairment after complete cryptococcal clearance were enrolled in this prospective study. Neurocognitive assessment, clinical examination and cerebrospinal fluid (CSF) assays were performed before and after lenalidomide treatment. Results: After lenalidomide treatment, the Montreal Cognitive Assessment [week (W) 0 (median [interquartile range]: 23.0 (13.0-24.0) vs W24: 26.0 (24.0-28.00), P=0.018] and International HIV Dementia Scale scores [W0: 9.0 (2.5-10.5) vs W24: 11.0 (10.00-12.0), P=0.028] improved significantly, mainly in the domain of memory function. There was no significant difference in the Center for Epidemiological Research Depression scores for anxiety and depression before and after treatment. Further stratified analyses revealed that the patients with cognitive improvement group had higher levels of CSF white blood cells [94.0 (44.0-180.0) vs 0 (0-1.5), P=0.032], CSF protein [4.9 (3.0-6.6) vs 0.6 (0.5-0.7), P=0.034], CSF albumin [318.5 (190.9-346.5) vs 33.5 (30.4-46.2), P=0.034], and CSF IgG [160.5 (73.8-256. 0) vs 4.7 (4.3-7.4), P=0.034] but a lower CSF glucose level [2.4 (2.0-2.7) vs 2.8 (2.8-3.9), P=0.032] than the patients with cognitive non-improvement group before treatment. CSF inflammatory cytokines of the growth-related oncogene, interleukin [IL]-10, granulocyte-colony stimulating factor, IL-6, IL-8, complement factor H, tumor necrosis factor-alpha, and alpha-2 macroglobulin were obviously decreased in patients with cognitive improvement group after lenalidomide treatment. Conclusion: Lenalidomide potentially reduces cognitive impairment caused by immune reconstitution inflammatory syndrome in patients with HCM after cryptococcal clearance by inhibiting intracranial inflammation.
36131783	11	23	Lenalidomide	Chemical	MESH:D000077269
36131783	38	58	Cognitive Impairment	Disease	MESH:D003072
36131783	69	112	Immune Reconstitution Inflammatory Syndrome	Disease	MESH:D054019
36131783	116	124	Patients	Species	9606
36131783	130	133	HIV	Disease	MESH:D015658
36131783	142	165	Cryptococcal Meningitis	Disease	MESH:D016919
36131783	176	196	Cognitive impairment	Disease	MESH:D003072
36131783	213	241	human immunodeficiency virus	Species	12721
36131783	243	246	HIV	Species	12721
36131783	256	279	cryptococcal meningitis	Disease	MESH:D016919
36131783	281	284	HCM	Disease	MESH:D000092183
36131783	304	347	immune reconstitution inflammatory syndrome	Disease	MESH:D054019
36131783	403	415	lenalidomide	Chemical	MESH:D000077269
36131783	438	446	patients	Species	9606
36131783	452	455	HCM	Disease	MESH:D000092183
36131783	460	480	cognitive impairment	Disease	MESH:D003072
36131783	496	508	cryptococcal	Disease	MESH:D016919
36131783	520	528	Patients	Species	9606
36131783	548	551	HCM	Disease	MESH:D000092183
36131783	552	560	patients	Species	9606
36131783	566	583	neuroinflammation	Disease	MESH:D000090862
36131783	588	608	cognitive impairment	Disease	MESH:D003072
36131783	624	636	cryptococcal	Disease	MESH:D016919
36131783	805	817	lenalidomide	Chemical	MESH:D000077269
36131783	844	856	lenalidomide	Chemical	MESH:D000077269
36131783	1016	1028	HIV Dementia	Disease	MESH:D015658
36131783	1242	1252	Depression	Disease	MESH:D003866
36131783	1264	1271	anxiety	Disease	MESH:D001007
36131783	1276	1286	depression	Disease	MESH:D003866
36131783	1361	1369	patients	Species	9606
36131783	1684	1691	glucose	Chemical	MESH:D005947
36131783	1749	1757	patients	Species	9606
36131783	1872	1891	interleukin [IL]-10	Gene	3586
36131783	1893	1930	granulocyte-colony stimulating factor	Gene	1440
36131783	1932	1936	IL-6	Gene	3569
36131783	1938	1942	IL-8	Gene	3576
36131783	1944	1963	complement factor H	Gene	3075
36131783	1965	1992	tumor necrosis factor-alpha	Gene	7124
36131783	1998	2019	alpha-2 macroglobulin	Gene	2
36131783	2048	2056	patients	Species	9606
36131783	2096	2108	lenalidomide	Chemical	MESH:D000077269
36131783	2132	2144	Lenalidomide	Chemical	MESH:D000077269
36131783	2165	2185	cognitive impairment	Disease	MESH:D003072
36131783	2196	2239	immune reconstitution inflammatory syndrome	Disease	MESH:D054019
36131783	2243	2251	patients	Species	9606
36131783	2257	2260	HCM	Disease	MESH:D000092183
36131783	2267	2279	cryptococcal	Disease	MESH:D016919
36131783	2304	2329	intracranial inflammation	Disease	MESH:D007249
36131783	Association	3569	3586
36131783	Association	1440	3569
36131783	Association	3075	3576
36131783	Association	MESH:D016919	3075
36131783	Association	2	3075
36131783	Positive_Correlation	MESH:D000077269	MESH:D003866
36131783	Association	MESH:D007249	3075
36131783	Association	3569	3576
36131783	Association	1440	3576
36131783	Negative_Correlation	MESH:D000077269	3586
36131783	Association	1440	2
36131783	Association	1440	3586
36131783	Association	MESH:D007249	3569
36131783	Negative_Correlation	MESH:D000077269	MESH:D000092183
36131783	Association	3075	3569
36131783	Negative_Correlation	MESH:D000077269	MESH:D003072
36131783	Association	1440	3075
36131783	Association	MESH:D016919	1440
36131783	Negative_Correlation	MESH:D000077269	7124
36131783	Association	3075	7124
36131783	Association	MESH:D016919	2
36131783	Association	MESH:D007249	2
36131783	Negative_Correlation	MESH:D000077269	MESH:D015658
36131783	Association	1440	7124
36131783	Association	MESH:D007249	3586
36131783	Negative_Correlation	MESH:D000077269	3569
36131783	Association	2	3569
36131783	Association	MESH:D016919	3576
36131783	Association	MESH:D016919	7124
36131783	Association	MESH:D007249	7124
36131783	Association	MESH:D000077269	2
36131783	Negative_Correlation	MESH:D000077269	MESH:D054019
36131783	Negative_Correlation	MESH:D000077269	1440
36131783	Negative_Correlation	MESH:D000077269	MESH:D016919
36131783	Association	MESH:D016919	3586
36131783	Association	3569	7124
36131783	Association	3586	7124
36131783	Association	2	3586
36131783	Association	MESH:D016919	3569
36131783	Association	3576	7124
36131783	Association	2	3576
36131783	Association	MESH:D007249	3576
36131783	Association	3075	3586
36131783	Association	3576	3586
36131783	Association	MESH:D007249	1440
36131783	Negative_Correlation	MESH:D000077269	3576
36131783	Association	2	7124

